Compounds > oxazolidin-2-one
Page last updated: 2024-08-25

oxazolidin-2-one and Liver Steatosis

oxazolidin-2-one has been researched along with Liver Steatosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emfinger, CH; Fazio, S; Harris, RC; Kuklenyik, Z; Luu, T; Parks, BA; Shi, J; Stafford, JM; Trefts, E; Wasserman, DH; Zeng, F; Zhu, L1

Other Studies

1 other study(ies) available for oxazolidin-2-one and Liver Steatosis

ArticleYear
CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet.
    Diabetes, 2018, Volume: 67, Issue:12

    Topics: Animals; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Diet, High-Fat; Fatty Liver; Insulin Resistance; Mice; Mice, Transgenic; Oxazolidinones

2018